Skip to content

Therapeutic Uses of Psychedelics: The Essentials

December 7, 2018 DOI: 10.64239/pi-vl0604 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Review
Key findings Psychedelics increase brain connectivity, which may disrupt maladaptive processes underlying depression, addiction, and OCD.

Abstract

Psychedelics stimulate 5-HT2A receptors in the human brain This can produce profound changes in perceptions and sense of self with positive benefits on mood and wellbeing In the 1950s and 1960s psychedelics were tested in many studies as treatments for addiction and anxiety and mood disorders with considerable success These drugs were banned, since then very little research has occurred Recent brain imaging research with psychedelics has revealed they produce profound alterations in brain activity They allow more flexible and wide-ranging interactions (increased connectivity ) to occur This breakdown of ongoing routines probably explains how psychedelics can disrupt maladaptive brain processes such as depression, addiction, and OCD